| Status | Study |
| Not yet recruiting |
Study Name: Study of ALXN1210 in Children and Adolescents With Atypical Hemolytic Uremic Syndrome (aHUS) Condition: Atypical Hemolytic Uremic Syndrome (aHUS) Date: 2017-04-24 Interventions: Biological: ALXN1210 Single loading dose on Day 1, followed by regular maintenance dosing beginning on D |
| Recruiting |
Study Name: Single Arm Study of ALXN1210 in Complement Inhibitor Treatment-Naïve Adult and Adolescent Patients With Atypical Hemolytic Uremic Syndrome (aHUS) Condition: Atypical Hemolytic Uremic Syndrome (aHUS) Date: 2016-10-25 Interventions: Biological: ALXN1210 Single loading dose on Day 1, followe |
| Recruiting |
Study Name: Study of 'Vascular Competence' Profile and Endothelial Activation in the Hemolytic Uremic Syndrome in Children and Adults Condition: Hemolytic Uremic Syndrome Date: 2016-09-08 Interventions: Biological: Extra blood draw samples |
| Enrolling by invitation |
Study Name: The Role of Microparticles as a Biomarker Condition: Atypical Hemolytic Uremic Syndrome Thrombotic Thrombocytopenic Purpura Date: 2015-10-20 |
| Recruiting |
Study Name: Study Assessing an Algorithm-based Strategy of Eculizumab Discontinuation in Children and Adults With aHUS Condition: Atypical Hemolytic Uremic Syndrome Date: 2015-10-05 Interventions: Drug: eculizumab eculizumab discontinuation |
| Terminated |
Study Name: Complement Inhibition in aHUS Dialysis Patients Condition: Atypical Hemolytic Uremic Syndrome Date: 2015-05-26 Interventions: Drug: CCX168 |
| Recruiting |
Study Name: Azithromycin in Post Diarrheal Haemolytic and Uremic Syndrome Condition: Haemolytic and Uremic Syndrome Date: 2015-01-08 Interventions: Drug: Azithromycin ZITHROMAX & |
| Recruiting |
Study Name: Eculizumab in Shiga-toxin Related Hemolytic and Uremic Syndrome Pediatric Patients - ECULISHU Condition: Hemolytic Uremic Syndrome of Childhood Date: 2014-07-28 Interventions: Drug: Eculizumab |
| Completed |
Study Name: The Safety and Efficacy of Eculizumab in Japanese Patients With Atypical Hemolytic Uremic Syndrome (aHUS) Condition: Atypical Hemolytic Uremic Syndrome (aHUS) Date: 2012-12-04 Interventions: Drug: Eculizumab |
| Completed |
Study Name: To Characterize the Safety and Tolerability of Eculizumab in Two Japanese aHUS Patients Condition: ATYPICAL HEMOLYTIC UREMIC SYNDROME (AHUS) Date: 2012-12-04 |